Richard Gaynor - Jun 16, 2022 Form 4 Insider Report for INFINITY PHARMACEUTICALS, INC. (INFI)

Role
Director
Signature
/s/ Seth A. Tasker as attorney-in-fact for Richard Gaynor, M.D.
Stock symbol
INFI
Transactions as of
Jun 16, 2022
Transactions value $
$0
Form type
4
Date filed
6/16/2022, 08:43 PM
Previous filing
Jun 16, 2022
Next filing
Jul 8, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INFI Stock Option(right to buy) Award $0 +45K $0.00 45K Jun 16, 2022 Common Stock 45K $0.68 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests over a period of one year in equal quarterly installments beginning at the end of the first quarter after the date of grant, provided that the holder continues to serve as a director of the issuer.

Remarks:

Exhibit 24 - Limited Power of Attorney